HNRNPA2B1 and plasma cell myeloma: To determine the functional role of myeloma expressed hnRNPA2B1 in lytic bone lesions, we injected shA2B1 RPMI8226 cells into mouse femurs and caused fewer lytic lesions than did shCtrl RPMI8226 cells.